Consortia


EGRP's Definition of Consortia

The National Cancer Institute's (NCI) Epidemiology and Genomics Research Program (EGRP) defines a consortium as a group of scientists from multiple institutions who have agreed to participate in cooperative research efforts involving activities such as methods development and validation, pooling of information from more than one study for the purpose of combined analyses, and collaborative projects. Consortia are able to address scientific questions that cannot be addressed otherwise due to scope, resources, population size, or expertise. This cooperation usually involves multiple projects over an extended period of time. Consortia can also be referred to as collaboratives.

The creation of a consortium is independent from NCI and NIH funding mechanisms. Groups participating in a consortium may partner in the writing of research grant applications, but consortium activities are not limited to a specific grant/project.

For sources of support, view our compilation of NCI and NIH funding opportunities that are relevant to cancer epidemiology or contact an EGRP Program Director.

Return to Top

Cancer Epidemiology Consortia

The list below provides links to information about research consortia that may be of interest to cancer epidemiologists. It is not an exhaustive list. Access to resources is dependent on procedures outlined for each individual consortium. Consortia interested in being included in this list should contact NCIEpiConsortia@mail.nih.gov.

  • Bladder Cancer
    • International Consortium of Bladder Cancer (ICBC)
  • Brain Cancer
    • Brain Tumor Epidemiology Consortium (BTEC)
    • GLIOGENE
    • Pediatric Brain Tumor Consortium (PBTC)
  • Breast Cancer
    • African-American Breast Cancer Consortium
    • Asian Breast Cancer Consortium (ABCC)
    • Breast Cancer Association Consortium (BCAC)
    • Breast Cancer Consortium for Outcomes And Survival (BC2OS)
    • Breast Cancer Family Registry (B-CFR)
    • Consortium of Contralateral Breast Cancer (CCBC)
    • The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
    • Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA)
    • Lessons in Epidemiology and Genetics of Adult Cancer from Youth (LEGACY): a Cohort of Youth in Families from the Breast Cancer Family Registry
    • Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)
    • Women, Cancer and Radiation Exposure (WECARE)
  • Childhood Cancers
    • Childhood Leukemia International Consortium (CLIC)
    • International Childhood Cancer Cohort Consortium (I4C)
    • Pediatric Brain Tumor Consortium
  • Colorectal Cancer
    • African coloRectal cancer GrOup (ARGO)
    • Asian Colorectal Cancer Consortium (ACCC)
    • Colon Cancer Family Registry (C-CFR)
    • Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO)
    • Lynch Syndrome Screening Network (LSSN)
  • Endometrial Cancer
    • Epidemiology of Endometrial Cancer Consortium (E2C2)
  • Esophageal Cancer
    • Asian Barrett's Consortium
    • International Barrett's and Esophageal Adenocarcinoma Consortium (BEACON)
  • Head and Neck Cancer
    • International Head and Neck Cancer Epidemiology Consortium (INHANCE)
  • Kidney Cancer
    • International Consortium for Investigation of Inherited Renal Malignancies (I-ConFIRM)
  • Leukemia
    • Childhood Leukemia International Consortium (CLIC)
    • Chronic Lymphocytic Leukemia Research Consortium (CRC)
  • Liver
    • Hepatocellular Carcinoma Epidemiology Consortium (HCCEC)
  • Lung Cancer
    • Genetic Epidemiology of Lung Cancer (GELCC)
    • International Lung Cancer Consortium (ILCCO)
  • Lymphoma
    • International Lymphoma Epidemiology Consortium (InterLymph)
  • Ovarian Cancer
    • Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA)
    • Ovarian Cancer Association Consortium (OCAC)
    • Ovarian Cancer Cohort Consortium (OC3)
    • Ovarian Cancer in Women of African Ancestry (OCWAA)
    • Pacific Ovarian Cancer Research Consortium (POCRC)
    • Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)
  • Pancreatic Cancer
    • Pancreatic Cancer Case Control Consortium (PANC4)
    • Pancreatic Cancer Cohort Consortium
    • Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)
  • Prostate Cancer
    • Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1 and BRCA2 mutation carriers and controls (IMPACT)
    • International Consortium on Prostate Cancer Genetics (ICPCG)
    • Men of African Descent and Prostate Cancer (MADCaP)
    • Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL)
    • Prostate Cancer Transatlantic Consortium (CaPTC)
  • Skin Cancers
    • Genes, Environment and Melanoma (GEM)
    • Keratinocyte Carcinoma Consortium (KeraCon)
    • Melanoma Genetics Consortium (GenoMEL)
  • Testicular Cancer
    • Testicular Cancer Consortium (TECAC)
  • Multiple Cancers
    • African-Caribbean Cancer Consortium (AC3)
    • Asia Cohort Consortium
    • Cancer Genetics Network (CGN)
    • Clinical Cancer Genetics Community Research Network (CCGCRN)
    • Comprehensive Oncologic Emergencies Research Network (CONCERN)
    • Latin American Cancer Epidemiology Consortium (LACE)
    • Li-Fraumeni Exploration Consortium (LiFE)
    • NCI Cohort Consortium
    • Radiogenomics Consortium (RGC)
Key to Acronyms Used in Tables

  • EGRP - Epidemiology and Genomics Research Program
  • CDC - Centers for Disease Control and Prevention
  • DCB - Division of Cancer Biology
  • DCEG - Division of Cancer Epidemiology and Genetics
  • NCI - National Cancer Institute
  • NHGRI - National Human Genome Research Institute
  • NIEHS - National Institute of Environmental Health Sciences
  • NIGMS - National Institute of General Medical Sciences
  • NIH - National Institutes of Health
  • OCS - Office of Cancer Survivorship
  • OD - Office of the Director

Return to Top

Additional Research Consortia

A number of additional research consortia conduct research to better understand determinants of various health outcomes in human populations, which may influence cancer risk. Some of the collaborations in which EGRP staff participate include:

Return to Top

Role of EGRP

EGRP fosters consortia through the following activities:

  • Advising investigators on the formation of new consortia
  • Advising consortia on policies and processes related to funding, data sharing, and collaborations
  • As appropriate, participating on steering or executive committees or working groups.

Questions about EGRP and Consortia can be sent to NCIEpiCommunications@mail.nih.gov.

Return to Top

Data Sharing

EGRP supports compliance with the NIH Data Sharing Policy and Genomic Data Sharing Policy. Data sharing is essential for expedited translation of research results into knowledge, products, and procedures to improve human health. To help investigators comply with these policies, NCI and NIH support a number of data repositories to help facilitate efficient data sharing, including the database of Genotypes and Phenotypes (dbGaP) and the Cancer Epidemiology Data Repository (CEDR).

Return to Top

African-American Breast Cancer Consortium

Since 2008

NIH Contacts

EGRP/NCI:

Consortium Liaison:
Damali Martin, Ph.D., M.P.H.

Lead Investigators:

Chris Haiman, Ph.D.
Norris Comprehensive Cancer Center,
University of Southern California

Funmi Olopade, M.D.
The University of Chicago

Julie Palmer, Sc.D.
Boston University

Asian Breast Cancer Consortium (ABCC)

Since 2008

NIH Contacts

EGRP/NCI:

ABCC Liaison:
Gabriel Lai, Ph.D.

Lead Investigator:

Wei Zheng, M.D., Ph.D.
Vanderbilt University School of Medicine
University of Southern California

African-Caribbean Cancer Consortium (AC3)

Visit Consortium WebsiteExternal Web Site Policy

Since 2006

NIH Contacts

EGRP/NCI:

AC3 Liaison:
Damali Martin, Ph.D., M.P.H.

Lead Investigator:

Camille Ragin Ph.D., M.P.H.
Fox Chase Cancer Center

Asian Colorectal Cancer Consortium (ACCC)

Since 2008

NIH Contacts

EGRP/NCI:

ACCC Liaison:
Gabriel Lai, Ph.D.

Lead Investigator:

Wei Zheng, M.D., Ph.D.
Vanderbilt University School of Medicine
University of Southern California

African coloRectal cancer GrOup (ARGO)

Since 2013

NIH Contacts

EGRP/NCI:

EGRP Liaison:
Krista Zanetti, Ph.D., M.P.H., R.D.

Lead Investigators:

Isaac Alatise, M.D.
Obafemi Awolowo University Teaching Hospital
Ile Ife, Nigeria

Peter Kingham, M.D.
Memorial Sloan Kettering Cancer Center

Asian Cohort Consortium

Visit Consortium WebsiteExternal Web Site Policy

Since 2004

NIH Contacts

EGRP/NCI:

ACC Liaison:
Gabriel Lai, Ph.D.

DCEG/NCI:

Rashmi Sinha, Ph.D.

Lead Investigators:

John Potter M.D. Ph.D.
Fred Hutchinson Cancer Research Center

Daehee Kang, M.D., Ph.D.
Seoul National University College of Medicine, Korea

Asian Barrett's Consortium

Since 2008

NIH Contacts

EGRP/NCI:

Consortium Liaison:
Gabriel Lai, Ph.D.

DCEG/NCI:

Wong-Ho Chow, Ph.D.

Sanford M. Dawsey, M.D.

Lead Investigator:

Lawrence Ho, M.B.B.S., M.D., F.R.A.C.P., F.A.M.S., F.R.C.P.
National University of Singapore

Breast Cancer Consortium for Outcomes And Survival (BC2OS)

Since 2007

NIH Contacts

EGRP/NCI:

BC2OS Liaison:
Joanne Elena, Ph.D., M.P.H.

OCS/NCI:

Julia Rowland, Ph.D.

Lead Investigator:

Larry Kushi
Kaiser Foundation Research Institute

Breast Cancer Association Consortium (BCAC)

Since 2005

Visit Consortium WebsiteExternal Web Site Policy NIH Contacts

Lead Investigators:

Douglas Easton, Ph.D.
University of Cambridge

Paul Pharoah, Ph.D.
Cambridge Cancer Center

Georgia Chenevix-Trench, Ph.D.
Queensland Institute of Medical Research

Manjeet Humphreys
University of Cambridge

Breast Cancer Family Registry (B-CFR)

Visit Consortium WebsiteExternal Web Site Policy

Since 1995

NIH Contacts

EGRP/NCI:

B-CFR Liaison:
Scott Rogers, M.P.H. (for Informatics)

Lead Investigators:

Irene Andrulis, Ph.D.
Cancer Care Ontario

Saundra Buys, M.D.
University of Utah Health Sciences Center

Mary Daly, M.D., Ph.D.
Fox Chase Cancer Center

John Hopper, Ph.D.
University of Melbourne

Esther John, Ph.D., M.S.P.H.
Cancer Prevention Institute of California

Mary Beth Terry, Ph.D.
Columbia University

International Barrett's and Esophageal Adenocarcinoma Consortium (BEACON)

Visit Consortium WebsiteExternal Web Site Policy

Since 2005

NIH Contacts

EGRP/NCI:

BEACON Liaison:
Gabriel Lai, Ph.D.

DCEG/NCI:

Wong-Ho Chow, Ph.D.

Lead Investigator:

Includes various EGRP-supported investigators teamed with DCEG investigators.

Thomas Vaughan, Ph.D., M.H.S.A.

Brain Tumor Epidemiology Consortium (BTEC)

Visit Consortium WebsiteExternal Web Site Policy

Since 2003

NIH Contacts

EGRP/NCI:

BTEC Liaison:
Melissa Rotunno, Ph.D.

DCEG/NCI:

Preetha Rajaraman, Ph.D.

Lead Investigators:

Luc Bauchet, M.D., Ph.D.
Centre Hospitalo-Universitaire (CHU) and National Institute of Health and Medical Research (INSERM), Montpellier, France

Joe Wiemels, Ph.D.
University of California, San Francisco

Prostate Cancer Transatlantic Consortium (CaPTC)

Visit Consortium Website

Since 2005

NIH Contacts

EGRP/NCI:

CaPTC Liaison:
Damali Martin, Ph.D., M.P.H.

Lead Investigator:

Folakemi T. Odedina, Ph.D.
University of Florida College of Pharmacy and Shands Cancer Center

Consortium of Contralateral Breast Cancer (CCBC)

Since 2011

NIH Contacts

EGRP/NCI:

CCBC Liaison:
Joanne Elena, Ph.D., M.P.H.

Lead Investigator:

Jonine Bernstein, Ph.D.
Memorial Sloan-Kettering Cancer Center

Colon Cancer Family Registry (C-CFR)

Visit Consortium WebsiteExternal Web Site Policy

Since 1997

NIH Contacts

EGRP/NCI:

C-CFR Liaison:
Scott Rogers, M.P.H. (for Informatics)

Lead Investigators:

Robert Haile, Dr.P.H.
Stanford University

Noralane (Laney) Lindor, M.D.
Mayo Clinic

Steve Gallinger, M.D.
Mount Sinai Hospital
Cancer Care Ontario

John Hopper, Ph.D.
University of Melbourne

Loic Le Marchand, M.D., Ph.D.
University of Hawaii at Manoa

Polly Newcomb, Ph.D., M.P.H.
Fred Hutchinson Cancer Research Center

Clinical Cancer Genetics Community Research Network (CCGCRN)

Visit Consortium WebsiteExternal Web Site Policy

Since 2014

NIH Contacts

Lead Investigator:

Jeff Weitzel, M.D.
City of Hope

Research Administrator:

Sharon Sand, C.C.R.P.
City of Hope

Cancer Genetics Network (CGN)

Visit Consortium WebsiteExternal Web Site Policy

Since 1998

NIH Contacts

EGRP/NCI:

CGN Liaison:
Scott Rogers, M.P.H.

Lead Investigator:

Dianne L. Finkelstein, Ph.D.
Massachusetts General Hospital

The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Visit Consortium WebsiteExternal Web Site Policy

Since 2005

NIH Contacts

EGRP/NCI:

CIMBA Liaison:
Damali Martin, Ph.D., M.P.H.

Lead Investigators:

Georgia Chenevix-Trench, Ph.D.
Queensland Institute of Medical Research

Douglas Easton, Ph.D.
University of Cambridge

Timothy Rebbeck, Ph.D.
Harvard University

Childhood Leukemia International Consortium (CLIC)

Visit Consortium WebsiteExternal Web Site Policy

Since 2006

NIH Contacts

EGRP/NCI:

CLIC Liaison:
Somdat Mahabir, Ph.D., M.P.H.

Lead Investigator:

Catherine Metayer, M.D., Ph.D.
University of California, Berkley

Project Manager:

Alice Kang
University of California, Berkley

Chronic Lymphocytic Leukemia Research Consortium (CRC)

Visit Consortium WebsiteExternal Web Site Policy

Since 2006

NIH Contacts

Lead Investigator:

Includes various EGRP-funded investigators teamed with DCEG investigators.

Thomas Kipps, Ph.D., M.D.
University of California, San Diego

Manager

Andrew W. Greaves
University of California, San Diego

NCI Cohort Consortium

Visit Consortium Website

Since 2000

NIH Contacts

EGRP/NCI:

NCI Cohort Consortium Liaison:
Nonye Harvey, M.P.H.

DCCPS/NCI:

Deborah Winn, Ph.D.

DCEG/NCI:

Robert Hoover, M.D., Sc.D.

Lead Investigators:

Elio Riboli, M.D., M.P.H., M.Sc. (Chair)
Imperial College

Leslie Bernstein, Ph.D.
City of Hope National Medical Center and Beckman Research Institute

William J. Blot, Ph.D.
Vanderbilt University and International Epidemiology Institute, Ltd.

Susan Gapstur, Ph.D., M.P.H.
American Cancer Society, Inc.

Mattias Johansson, Ph.D.
International Agency for Research on Cancer (IARC/WHO)

Meir Stampfer, M.D, Dr. P.H.
Harvard Medical School, Harvard School of Public Health, and Brigham and Women's Hospital

Anthony Swerdlow, Ph.D., M.P.H.
University of London, Institute of Cancer Research

Wei Zheng, M.D., Ph.D., M.P.H.
Vanderbilt University Medical Center

Comprehensive Oncologic Emergencies Research Network (CONCERN)

Visit Consortium Website

Since 2015

NIH Contacts

Lead Investigators:

Jeff Caterino, M.D.
The Ohio State University

Corita Grudzen, M.D.
NYU Langone Medical Center

Demetrious (Jim) Kyriacou, M.D., Ph.D.
Northwestern University

Epidemiology of Endometrial Cancer Consortium (E2C2)

Visit Consortium Website

Since 2006

NIH Contacts

EGRP/NCI:

E2C2 Liaison:
Leah Mechanic, Ph.D., M.P.H.

DCEG/NCI:

Hannah Yang, Ph.D., Sc.M.

Lead Investigator:

Sara Olson, Ph.D.
Memorial Sloan-Kettering Cancer Center

Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA)

Visit Consortium WebsiteExternal Web Site Policy

Since 2009

NIH Contacts

EGRP/NCI:

ENIGMA Liaison:
Melissa Rotunno, Ph.D.

Lead Investigator:

David Goldgar, Ph.D.
University of Utah

Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO)

Visit Consortium WebsiteExternal Web Site Policy

Since 2008

NIH Contacts

EGRP/NCI:

GECCO Liaison:
Leah Mechanic, Ph.D., M.P.H.

Lead Investigator:

Ulrike Peters, Ph.D., M.P.H.
University of Washington School of Public Health

Genetic Epidemiology of Lung Cancer (GELCC)

Visit Consortium WebsiteExternal Web Site Policy

Since 1999

NIH Contacts

Lead Investigator:

Marshall Anderson, Ph.D.
University of Cincinnati

Genes, Environment and Melanoma (GEM)

Visit Consortium WebsiteExternal Web Site Policy

Since 1999

NIH Contacts

EGRP/NCI:

GEM Liaison:
Damali Martin, Ph.D., M.P.H.

Lead Investigator:

Marianne Berwick, Ph.D., M.P.H.
University of New Mexico

Melanoma Genetics Consortium (GenoMEL)

Visit Consortium WebsiteExternal Web Site Policy

Since 1997

NIH Contacts

Lead Investigators:

Peter Kanetsky
Moffitt Cancer Center

Julia Newton-Bishop, M.D.
Leeds Cancer Centre at St James's University Hospital, England

GLIOGENE

Visit Consortium WebsiteExternal Web Site Policy

Since 2007

NIH Contacts

EGRP/NCI:

GLIOGENE Liaison:
Melissa Rotunno, Ph.D.

Lead Investigator:

Melissa Bondy, Ph.D.
Baylor College of Medicine

Hepatocellular Carcinoma Epidemiology Consortium (HCCEC)

Visit Consortium WebsiteExternal Web Site Policy

Since 2011

NIH Contacts

EGRP/NCI:

HCC Liaison:
Gabriel Lai, Ph.D.

Lead Investigators:

Manal M. Hassan, M.B. B.C.H., M.P.H., Ph.D.
University of Texas M.D. Anderson Cancer Center

Hashem B. El-Serag, M.D., M.P.H.
Baylor College of Medicine

International Childhood Cancer Cohort Consortium (I4C)

Visit Consortium Website

Since 2005

NIH Contacts

Lead Investigator:

Includes various EGRP-funded investigators teamed with DCEG investigators.

Terry Dwyer, A.O., M.D., M.P.H.
Murdoch Childrens Research Institute, Melbourne

International Consortium of Bladder Cancer (ICBC)

Visit Visit Consortium Website

Since 2005

NIH Contacts

Lead Investigator:

Xifeng Wu, M.D., Ph.D.
The University of Texas M. D. Anderson Cancer Center

International Consortium for Investigation of Inherited Renal Malignancies (I-ConFIRM)

Visit Consortium Website

Since 2013

NIH Contacts

EGRP/NCI:

I-ConFIRM Liaison:
Krista A. Zanetti, Ph.D., M.P.H., R.D.

Lead Investigators:

Gianluca Severi, Ph.D.
Centre for Research in Epidemiology and Population Health, INSERM, Paris South University

Eamonn Maher, B.Sc., M.D., F.R.C.P., F.Med.Sci.
University of Cambridge

Loren Lipworth, Sc.D.
Vanderbilt University

Fiona Bruinsma, Dr.P.H.
Cancer Council Victoria

Ingrid Winship, M.B.Ch.B., M.D., F.R.A.C.P., F.A.C.D., F.A.I.C.D.
University of Melbourne

International Consortium on Prostate Cancer Genetics (ICPCG)

Visit Consortium WebsiteExternal Web Site Policy

Since 1996

NIH Contacts

Lead Investigator:

Includes various EGRP-funded investigators teamed with NHGRI investigators.

Stephen N. Thibodeau, Ph.D.
Mayo Clinic

International Lung Cancer Consortium (ILCCO)

Visit Consortium WebsiteExternal Web Site Policy

Since 2004

NIH Contacts

Lead Investigator:

Rayjean J. Hung, Ph.D., M.S.
Samuel Lunenfeld Research Institute
Cancer Care Ontario

Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1 and BRCA2 mutation carriers and controls (IMPACT)

Visit Consortium WebsiteExternal Web Site Policy

Since 2005

NIH Contacts

EGRP/NCI:

IMPACT Liaison:
Rao L. Divi, Ph.D.

Lead Investigator:

Rosalind Eeles, Ph.D.
The Institute of Cancer Research, UK

International Head and Neck Cancer Epidemiology Consortium (INHANCE)

Visit Consortium WebsiteExternal Web Site Policy

Since 2004

NIH Contacts

DCCPS/NCI:

INHANCE Liaison:
Gabriel Lai, Ph.D.
Deborah M. Winn, Ph.D.

Lead Investigators:

Mia Hashibe, M.P.H., Ph.D.
University of Utah School of Medicine

International Lymphoma Epidemiology Consortium (InterLymph)

Visit Consortium Website

Since 2001

NIH Contacts

EGRP/NCI:

InterLymph Liaison:
Rao Divi, Ph.D.

DCEG/NCI:

Martha Linet, M.D., M.P.H.

Lead Investigators:

Alexandra Nieters, Ph.D.
Head of Clinical Research Unit
Center for Chronic Immunodeficiency
Medical Center - University of Freiburg

Sophia Wang, Ph.D.
Associate Professor
Cancer Etiology
City of Hope

Claire Vajdic, Ph.D.
Cancer Aetiology and Prevention Group
Prince of Wales Clinical School
University of New South Wales, Australia

Keratinocyte Carcinoma Consortium (KeraCon)

Since 2014

NIH Contacts

EGRP/NCI:

KeraCon Liaison:
Gabriel Lai, Ph.D.

Lead Investigators:

Martin Weinstock, M.D., Ph.D.
Brown University

Leah Ferrucci, Ph.D., M.P.H.
Yale School of Public Health

Latin American Cancer Epidemiology Consortium (LACE)

Since 2008

NIH Contacts

EGRP/NCI:

LACE Liaison:
Tram Kim Lam, Ph.D., M.P.H.

NCI/OD

Jorge Gomez, M.D., Ph.D.
Office of Latin American Cancer Program Development

Lead Investigators:

Robert Haile, Dr.P.H.
Stanford University

Lessons in Epidemiology and Genetics of Adult Cancer from Youth (LEGACY): a Cohort of Youth in Families from the Breast Cancer Family Registry

Visit Consortium WebsiteExternal Web Site Policy

Since 2011

NIH Contacts

EGRP/NCI:

LEGACY Liaison:
Gabriel Lai, Ph.D.

Lead Investigators:

Esther M. John, Ph.D., M.S.P.H.
Cancer Prevention Institute of California

Mary Beth Terry, Ph.D.
Columbia University Medical Center

Mary B. Daly, M.D., Ph.D.
Fox Chase Cancer Center

Irene L. Andrulis, Ph.D.
Samuel Lunenfeld Research Institute, Mt. Sinai Hospital

Saundra Buys, M.D.
Huntsman Cancer Institute

Li-Fraumeni Exploration Consortium (LiFE)

Visit Consortium WebsiteExternal Web Site Policy

Since 2010

NIH Contacts

Lead Investigators:

David Malkin, M.D.
University of Toronto

Judy Garber, M.D., M.P.H.
Dana-Farber Cancer Institute

Louise Strong, M.D.
The University of Texas M.D. Anderson Cancer Center

Pierre Hainaut, Ph.D.
International Agency for Research on Cancer

Maria Isabel Achatz, M.D., Ph.D.
Hospital A.C. Carmargo-Fundação Antonio Prudente, São Paulo, Brazil

Lynch Syndrome Screening Network (LSSN)

Visit Consortium WebsiteExternal Web Site Policy

Since 2011

NIH Contacts

Lead Investigators:

Debra Duquette, M.S., C.G.C.
Michigan Department of Community Health

Sarah Mange, M.P.H.
Michigan Deptartment of Community Health

Cecelia A. Bellcross, Ph.D., M.S., C.G.C.
Emory University School of Medicine

Kory Jasperson, M.S., C.G.C.
Huntsman Cancer Institute

Heather Hampel, M.S., C.G.C.
Ohio State University

Men of African Descent and Prostate Cancer (MADCaP)

Visit Consortium Website

Since 2007

NIH Contacts

EGRP/NCI:

MADCaP Liaison:
Damali Martin, Ph.D., M.P.H.

DCEG/NCI

Anne Hsing, Ph.D.

Lead Investigator:

Timothy Rebbeck, Ph.D.
Harvard University

Ovarian Cancer Cohort Consortium (OC3)

Visit Consortium WebsiteExternal Web Site Policy

Since 2009

NIH Contacts

Lead Investigators:

Shelley Tworoger, Ph.D.
Harvard University School of Public Health

Alan Arslan, M.D.
New York University

Ovarian Cancer Association Consortium (OCAC)

Visit Consortium WebsiteExternal Web Site Policy

Since 2005

NIH Contacts

Lead Investigator:

Andrew Berchuck, M.D.
Duke University Comprehensive Cancer Center

Ovarian Cancer in Women of African Ancestry (OCWAA)

Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)

Visit Consortium WebsiteExternal Web Site Policy

Since 2002

NIH Contacts

EGRP/NCI:

PACGENE Liaison:
Gabriel Lai, Ph.D.

Lead Investigator:

Gloria Petersen, Ph.D.
Mayo Clinic

Pancreatic Cancer Case Control Consortium (PANC4)

Visit Consortium WebsiteExternal Web Site Policy NIH Contacts

EGRP/NCI:

PANC4 Liaison:
Gabriel Lai, Ph.D.

Lead Investigator:

Gloria Petersen, Ph.D.
Mayo Clinic

Pancreatic Cancer Cohort Consortium

Visit Consortium Website

Since 2006

NIH Contacts

Pediatric Brain Tumor Consortium (PBTC)

Visit Consortium WebsiteExternal Web Site Policy

Since 1999

NIH Contacts

EGRP/NCI:

PBTC Liaison:
Mukesh Verma, Ph.D.

DCEG/NCI:

Peter Inskip, Sc.D.

Lead Investigator:

Includes various EGRP-funded investigators teamed with DCEG investigators.

Patricia Buffler, Ph.D, M.P.H.
University of California, Berkeley

Pacific Ovarian Cancer Research Consortium (POCRC)

Since 1999

NIH Contacts

EGRP/NCI:

POCRC Liaison:
Tram Kim Lam, Ph.D., M.P.H.

Lead Investigator:

Nicole Urban, Ph.D.
University of Washington School of Public Health

Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL)

Visit Consortium WebsiteExternal Web Site Policy

Since 2007

NIH Contacts

EGRP/NCI:

PRACTICAL Liaison:
Danielle Daee, Ph.D.

Lead Investigators:

Rosalind Eeles, Ph.D.
The Institute of Cancer Research, UK

Zsofia Kote-Jarai, Ph.D.
The Institute of Cancer Research, UK

Douglas Easton, Ph.D.
University of Cambridge and Cancer Research UK

Sara Benlloch Garcia (Coordinator)
University of Cambridge

Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)

NIH Contacts

EGRP/NCI:

PROSE Liaison:
Rao L. Divi, Ph.D.

Lead Investigators:

Timothy Rebbeck, Ph.D.
Harvard University

Radiogenomics Consortium (RGC)

Visit Consortium Website

Since 2009

NIH Contacts

EGRP/NCI:

Radiogenomics Consortium Liaison:
Nonniekaye Shelburne, C.R.N.P., M.S., A.O.C.N.

DCEG/NCI:

Alice Sigurdson, Ph.D.

Lead Investigators:

Barry Rosenstein, Ph.D.
Mount Sinai School of Medicine

Catharine West, Ph.D.
University of Manchester School of Medicine

Testicular Cancer Consortium (TECAC)

Visit Consortium WebsiteExternal Web Site Policy

Since 2012

NIH Contacts

Lead Investigator:

Stephen M. Schwartz, Ph.D.
Fred Hutchinson Cancer Research Center

Women, Cancer and Radiation Exposure (WECARE)

Visit Consortium WebsiteExternal Web Site Policy

Since 2002

NIH Contacts

EGRP/NCI:

WECARE Liaison:
Gabriel Lai, Ph.D.

Lead Investigators:

Jonine Bernstein, Ph.D.
Memorial Sloan-Kettering Cancer Center